Diabetes News and Research

Latest Diabetes News and Research

Panel releases draft priorities for comparative effectiveness research

The draft, which offered insight into the Patient-Centered Outcomes Research Institute's priorities and research agenda, did not single out any specific diseases or treatments. The Institute did seek public comment.

25 Jan 2012

CHF associated with reduced patency after peripheral endovascular intervention

Congestive heart failure (CHF) is a highly prevalent comorbidity among patients with symptomatic peripheral arterial disease. The effect of CHF on the procedural success of endovascular treatment, however, remains unknown.

25 Jan 2012

Genetic variation predisposes children to complications linked with second-generation anti-psychotics

Researchers have found a genetic variation predisposing children to six-times greater risk of developing metabolic syndrome when taking second-generation anti-psychotic medications. Metabolic syndrome is a cluster of conditions that are risk factors for cardiovascular disease.

25 Jan 2012

One-year results from Covidien's EverFlex stent trial on P.A.D.

Covidien, a leading global provider of healthcare products, today announced that one-year results on the use of its EverFlex stent for superficial femoral artery stenting were presented here during the International Symposium on Endovascular Therapy (ISET) Conference.

25 Jan 2012

Link between high fructose intake and cardiovascular risk in adolescents

Evidence of cardiovascular disease and diabetes risk is present in the blood of adolescents who consume a lot of fructose, a scenario that worsens in the face of excess belly fat, researchers report.

25 Jan 2012

Echo commences Symphony tCGM System trials in critical care patients

Echo Therapeutics, Inc., a company developing the Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude SkinPrep System for transdermal drug delivery, today announced that it is initiating clinical studies of its Symphony tCGM System in critical care patients.

25 Jan 2012

Viewpoints: Obama and liberal Catholics; Growing 'charity care'; Cutting costs on physician referrals

A Health and Human Services mandate that forces every employer to provide employees with health coverage that not only covers birth control and sterilization, but makes them free ... has drawn fire from the Catholic bishops. Less predictable - and far more interesting - has been the heat from the Catholic left, including many who have in the past given the president vital cover. In a post for the left-leaning National Catholic Reporter, Michael Sean Winter minces few words. Under the headline "J'ACCUSE," he rightly takes the president to the woodshed for the politics of the decision.

25 Jan 2012

Roche proposes to acquire Illumina for $44.50 per share

Roche announced today that it is proposing to acquire all outstanding shares of Illumina, Inc. for $44.50 per share in cash, or an aggregate of approximately $5.7 billion on a fully diluted basis.

From Roche Sequencing and Life Science 24 Jan 2012

Johnson & Johnson fourth quarter sales increase 3.9% to $16.3 billion

Johnson & Johnson today announced sales of $16.3 billion for the fourth quarter of 2011, an increase of 3.9% as compared to the fourth quarter of 2010. Operational sales increased 4.0% and the negative impact of currency was 0.1%.

24 Jan 2012

Brown fat burns in the cold and could hold key to burning excess fat: Study

Brown fat is something that occurs more in thin people than fat, younger people than older and young women than men. It is brown in color and a new study finds that one form of it, which is turned on in cold climates can burn calories from elsewhere in the body to keep the body warm. Another new study finds that a second form of brown fat can be created from ordinary white fat by exercise.

24 Jan 2012

Stem cells show promise in treating blindness

A medical breakthrough was reported Monday in the journal The Lancet wherein the results of a therapy using human embryonic stem cells in two legally blind patients was described.

24 Jan 2012

More efficient diagnostic tools are not always used for neuropathy patients

Researchers at the University of Michigan analyzed the tremendous cost of diagnosing peripheral neuropathy and found that less expensive, more effective tests are less likely to be used.

24 Jan 2012

Exposure to iodinated contrast media may increase risk of hyperthyroidism

Exposure to iodinated contrast media during imaging procedures is associated with changes in thyroid function, and increased risk of developing hyperthyroidism, according to a report in the January 23 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

24 Jan 2012

Researchers analyze tremendous cost of peripheral neuropathy diagnosis

Researchers at the University of Michigan analyzed the tremendous cost of diagnosing peripheral neuropathy and found that less expensive, more effective tests are less likely to be used.

24 Jan 2012

Study shows childhood experiences have long-term effects on health in midlife

Nurturing mothers have garnered accolades for rescuing skinned knees on the playground and coaxing their children to sleep with lullabies. Now they're gaining merit for their offspring's physical health in middle age.

24 Jan 2012

Viewpoints: Opposing views of HHS' contraception rule; Health care costs and the liberal agenda

The administration's rule leaves the decision in the hands of patients, where it belongs, while respecting the rights of religions. It holds true to the original and wise idea that access to preventive medicine is a good idea for the nation's physical and financial well-being.

24 Jan 2012

New sensor can detect glucose levels in human saliva

For the 26 million Americans with diabetes, drawing blood is the most prevalent way to check glucose levels. It is invasive and at least minimally painful. Researchers at Brown University are working on a new sensor that can check blood sugar levels by measuring glucose concentrations in saliva instead.

24 Jan 2012

Novo Nordisk Type 1 Diabetes R&D Center to be established in Seattle

Novo Nordisk announced today that the company will establish a type 1 diabetes research and development center in Seattle, Wash., U.S. The new center will combine Novo Nordisk's history of innovation and leadership in diabetes treatment with the company's growing expertise in immunotherapy.

24 Jan 2012

miR-375 can predict life threatening head and neck cancers

Researchers at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center, the University Hospital for Einstein, have found a biomarker in head and neck cancers that can predict whether a patient's tumor will be life threatening.

24 Jan 2012

Study takes a closer look at high fructose corn syrup and table sugar

With growing concern that excessive levels of fructose may pose a great health risk - causing high blood pressure, kidney disease and diabetes - researchers at the University of Colorado School of Medicine, along with their colleagues at the University of Florida, set out to see if two common sweeteners in western diets differ in their effects on the body in the first few hours after ingestion.

24 Jan 2012